An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nanette K. Wenger, MD
Emory University
Principal Investigator - Noel Bairey Merz, MD
Cedars-Sinai Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Alabama at Birmingham
Birmingham, Alabama, United States
- Cardiovascular Consultants, Ltd.
Phoenix, Arizona, United States
- Cardiology Consultants of Orange County
Anaheim, California, United States
- Access Clinical Trials/cardiovascular Research Institute (act/cvri)
Beverly Hills, California, United States
- Escondido Cardiology Associates
Escondido, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Mission Internal Medical Group
Mission Viejo, California, United States
- South Denver Cardiology Associates, Pc
Littleton, Colorado, United States
- Guerra Cardiology
Coral Gables, Florida, United States
- Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
- Jacksonville Heart Center, Pa
Jacksonville, Florida, United States
- Jacksonville Heart Center, Pa
Jacksonville, Florida, United States
- St. Luke Cardiology Associates
Jacksonville, Florida, United States
- Emory University & Grady Health System
Atlanta, Georgia, United States
- Mercy Physician Group Cardiology
Nampa, Idaho, United States
- North Shore Cardiology
Bannockburn, Illinois, United States
- Gateway Cardiology, P.C.
Jerseyville, Illinois, United States
- Northern Indiana Research Alliance
Fort Wayne, Indiana, United States
- Ashland Hospital Corporation D/b/a King'S Daughters Medical Center
Ashland, Kentucky, United States
- University of Louisville, Division of Cardiovascular Medicine
Louisville, Kentucky, United States
- Gateway Cardiology, P.C.
St Louis, Missouri, United States
- Integrated Cardiology Consultants, Llc D.B.A. Bryan Lgh Heart Institute
Lincoln, Nebraska, United States
- Albany Associates in Cardiology
Albany, New York, United States
- Total Heart Care, Pc
New York, New York, United States
- the Lindner Clinical Trial Center
Cincinnati, Ohio, United States
- St. Vincent Mercy Medical Center, Cardiac Research
Toledo, Ohio, United States
- Bluestem Cardiology
Bartlesville, Oklahoma, United States
- Tri-State Medical Group, Cardiology, Sewickley Valley Medical Group, Cardiology
Beaver, Pennsylvania, United States
- Cardiology Consultants of Philadelphia
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2007
- Primary completion
- 31 Jan 2011
- Completion
- 31 Jan 2011
- Last update posted
- 2 Jul 2012
- Registered enrollment
- 172
- Registry id
- NCT00644332
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.